ThromboGenics
ThromboGenics, now rebranded as Oxurion, is a biopharmaceutical company focused on the development of innovative treatments for vascular eye diseases. The company was formerly known for the development of Jetrea, a therapeutic agent used for the treatment of symptomatic vitreomacular adhesion.
Brand Identity Data
HQ Country
Belgium
HQ City
Heverlee
Founded
1985
EU Headquartered
Yes
EU Manufactured
Yes
Stock Exchange
Private
Repair / Recycling
No
Ethical Certifications
None verified
Verified on July 22, 2026